Open Innovation Networks in Indian Pharmaceutical Sector - Inospin | Inospin
blog-stethoscope

Open Innovation Networks in Indian Pharmaceutical Sector

< Back to all posts

  Biowebspin, February 04th, 2016

Open Innovation Networks in Indian Pharmaceutical Sector

by Bhawani Bhatnagar, Viktor Dörfler, Jillian MacBryde

The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected?

The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.

  Get Full text: PDF-icon
[wysija_form id="1"]
This article was relevant ? Share it with your contacts clicking on the buttons below
< Back to all posts